Cytori Therapeutics reported $4.92M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Baxter International BAX:US $ 3890M 346M
Cerus CERS:US $ 66.66M 11.9M
Cytori Therapeutics CYTX:US $ 4.92M 0.95M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Haemonetics HAE:US $ 442.27M 86.86M
Infinity Pharmaceuticals INFI:US $ 13.39M 0.09M
Merrimack Pharmaceuticals MACK:US $ 564K 2K
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Northwest Biotherapeutics NWBO:US 130.01M 3.76M
Starpharma Holdings Ltd SPL:AU 9.29M 1.14M
Teva Pharmaceutical TEVA:IT 11.61B 586M